Literature DB >> 15195929

Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides.

Ken J Ishii1, Ihsan Gursel, Mayda Gursel, Dennis M Klinman.   

Abstract

Bacterial DNA contains immunostimulatory CpG motifs that interact with toll-like receptor 9 on immune cells to stimulate the production of cytokines, chemokines and immunoglobulins. Synthetic oligodeoxynucleotides (ODNs) containing CpG motifs mimic the activity of bacterial DNA. Recently, several structurally distinct types of CpG ODN were identified that differentially activate human immune cells. These ODNs may be useful as vaccine adjuvants, anti-allergens and in the treatment of infectious diseases and cancer. Yet CpG-driven immune activation can have deleterious consequences, such as increasing the host's susceptibility to autoimmune disease. The immunomodulatory activity of CpG DNA can be blocked by DNA containing G-rich 'suppressive' motifs. The therapeutic potential of these immunostimulatory and immunosuppressive ODNs are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195929

Source DB:  PubMed          Journal:  Curr Opin Mol Ther        ISSN: 1464-8431


  13 in total

1.  The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells.

Authors:  Geanncarlo Lugo-Villarino; Shu-Ichi Ito; Dennis M Klinman; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-31       Impact factor: 11.205

Review 2.  Liposome-nucleic acid immunotherapeutics.

Authors:  Steven Dow
Journal:  Expert Opin Drug Deliv       Date:  2008-01       Impact factor: 6.648

Review 3.  Synthetic oligonucleotides as modulators of inflammation.

Authors:  Dennis Klinman; Hidekazu Shirota; Debra Tross; Takashi Sato; Sven Klaschik
Journal:  J Leukoc Biol       Date:  2008-04-22       Impact factor: 4.962

4.  A suppressive oligodeoxynucleotide expressing TTAGGG motifs modulates cellular energetics through the mTOR signaling pathway.

Authors:  Volkan Yazar; Gizem Kilic; Ozlem Bulut; Tugce Canavar Yildirim; Fuat C Yagci; Gamze Aykut; Dennis M Klinman; Mayda Gursel; Ihsan Gursel
Journal:  Int Immunol       Date:  2020-01-09       Impact factor: 4.823

5.  Structure-dependent modulation of alpha interferon production by porcine circovirus 2 oligodeoxyribonucleotide and CpG DNAs in porcine peripheral blood mononuclear cells.

Authors:  Frida Hasslung Wikström; Brian M Meehan; Mikael Berg; Sirje Timmusk; Josefine Elving; Lisbeth Fuxler; Mattias Magnusson; Gordon M Allan; Francis McNeilly; Caroline Fossum
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

6.  CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes.

Authors:  Tajie H Harris; John M Mansfield; Donna M Paulnock
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

7.  Preconditioning with intravenous colitic cell-free DNA prevents DSS-colitis by altering TLR9-associated gene expression profile.

Authors:  Györgyi Műzes; Ferenc Sipos; István Fűri; Miklós Constantinovits; Sándor Spisák; Barnabás Wichmann; Gábor Valcz; Zsolt Tulassay; Béla Molnár
Journal:  Dig Dis Sci       Date:  2014-09-13       Impact factor: 3.199

8.  Intravenous administration of a single-dose free-circulating DNA of colitic origin improves severe murine DSS-colitis.

Authors:  Ferenc Sipos; Györgyi Műzes; István Fűri; Sándor Spisák; Barnabás Wichmann; Tiana M Germann; Miklós Constantinovits; Tibor Krenács; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2014-04-11       Impact factor: 3.201

9.  Molecular mechanism of immune response induced by foreign plasmid DNA after oral administration in mice.

Authors:  Jian-Wen Liu; Jun Cheng
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

10.  Broad-spectrum drugs against viral agents.

Authors:  Mary E Christopher; Jonathan P Wong
Journal:  Int J Mol Sci       Date:  2008-09-01       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.